SUBLIVAC FIX Birch

DRUG2 trials

Sponsors

HAL Allergy

Conditions

Allergic RhinitisAllergic RhinoconjunctivitisBirch Pollen Induced Rhinitis/Rhinoconjunctivitis

Phase 2

SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding

CompletedNCT01639768

HAL AllergyAllergic Rhinitis, Allergic Rhinoconjunctivitis

Start: 2012-07-31End: 2013-04-30Updated: 2013-05-29

Phase 3

SUBLIVAC FIX Birch Phase III Short-term Efficacy

CompletedNCT02231307

HAL AllergyBirch Pollen Induced Rhinitis/Rhinoconjunctivitis

Start: 2014-09-30End: 2015-11-30Updated: 2016-09-23

Related Papers

Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma.

2018-11-3033 citations

A randomized <scp>DBPC</scp> trial to determine the optimal effective and safe dose of a <scp>SLIT</scp>‐birch pollen extract for the treatment of allergic rhinitis: results of a phase <scp>II</scp> study

Allergy2015-09-0346 citations